Item Type: | Review |
---|---|
Title: | Cellular senescence: defining a path forward |
Creators Name: | Gorgoulis, V., Adams, P.D., Alimonti, A., Bennett, D.C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., Gil, J., Hara, E., Krizhanovsky, V., Jurk, D., Maier, A.B., Narita, M., Niedernhofer, L., Passos, J.F., Robbins, P.D., Schmitt, C.A., Sedivy, J., Vougas, K., von Zglinicki, T., Zhou, D., Serrano, M. and Demaria, M. |
Abstract: | Cellular senescence is a cell state implicated in various physiological processes and a wide spectrum of age-related diseases. Recently, interest in therapeutically targeting senescence to improve healthy aging and age-related disease, otherwise known as senotherapy, has been growing rapidly. Thus, the accurate detection of senescent cells, especially in vivo, is essential. Here, we present a consensus from the International Cell Senescence Association (ICSA), defining and discussing key cellular and molecular features of senescence and offering recommendations on how to use them as biomarkers. We also present a resource tool to facilitate the identification of genes linked with senescence, SeneQuest (available at http://Senequest.net). Lastly, we propose an algorithm to accurately assess and quantify senescence, both in cultured cells and in vivo. |
Keywords: | Aging, Biomarkers, Cell Cycle Checkpoints, Cellular Senescence, Chromatin, Gene Expression Regulation, Inborn Genetic Diseases |
Source: | Cell |
ISSN: | 0092-8674 |
Publisher: | Cell Press |
Volume: | 179 |
Number: | 4 |
Page Range: | 813-827 |
Date: | 31 October 2019 |
Additional Information: | Copyright © 2019 Elsevier Inc. |
Official Publication: | https://doi.org/10.1016/j.cell.2019.10.005 |
External Fulltext: | View full text on external repository or document server |
PubMed: | View item in PubMed |
Repository Staff Only: item control page